- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Study affirms safety of adenosine test
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
Study affirms safety of adenosine test
By: James Brice
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
A study of adenosine safety conducted by researchers at St. Marien Hospital in Bonn, Germany, may put those concerns to rest. Dr. Karol Miszlaski-Jamka did record minor side effects, such as facial flushing and mild shortness of breath, in 81% of the 645 patients who underwent adenosine-stress contrast MR. But major side effects were limited, including 23 cases of transient high-degree atrioventricular block that resolved spontaneously, one case of severely increased blood pressure, and two instances of claustrophobia.
Study affirms safety . . .
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
